The effect of TCAs on CYP2D6 activity in vivo

被引：0
|
作者：
Szewczuk-Boguslawska, M. [1 ]
Kiejna, A. [1 ]
Beszlej, J. [1 ]
Orzechowska-Juzwenko, K. [1 ]
机构：
[1] Univ Med, Wroclaw, Poland
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S251 / S251
页数：1
相关论文
共 50 条
  • [41] Catalytic in vivo function of CYP2D6 in relation to the genotype
    Griese, EU
    Gaedigk, A
    Morike
    Mikus, G
    Zanger, U
    Eichelbaum, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 458 - 458
  • [42] More data for the CYP2D6 hypothesis?:: The in vivo inhibition of CYP2D6 isoenzyme and extrapyramidal symptoms induced by antidepressants in the elderly
    García-Parajuá, P
    de Ugarte, L
    Baca, E
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (01) : 111 - 112
  • [43] Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6-Mediated Metabolic Activity
    Dalton, Rachel
    Lee, Seung-been
    Claw, Katrina G.
    Prasad, Bhagwat
    Phillips, Brian R.
    Shen, Danny D.
    Wong, Lai Hong
    Fade, Mitch
    McDonald, Matthew G.
    Dunham, Maitreya J.
    Fowler, Douglas M.
    Rettie, Allan E.
    Schuetz, Erin
    Thornton, Timothy A.
    Nickerson, Deborah A.
    Gaedigk, Andrea
    Thummel, Kenneth E.
    Woodahl, Erica L.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (01): : 147 - 156
  • [44] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [45] CYP2D6 genotypes in a Japanese population:: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10
    Nishida, Y
    Fukuda, T
    Yamamoto, I
    Azuma, J
    PHARMACOGENETICS, 2000, 10 (06): : 567 - 570
  • [46] No effect of the new antidepressant reboxetine on CYP2D6 activity in healthy volunteers
    Avenoso, A
    Facciolà, G
    Scordo, MG
    Spina, E
    THERAPEUTIC DRUG MONITORING, 1999, 21 (05) : 577 - 579
  • [47] The Effect of Tamoxifen Dose Increment in Patients With Impaired CYP2D6 Activity
    Welzen, Marieke E. B.
    Dezentje, Vincent O.
    van Schaik, Ron H. N.
    Colbers, Angela P. H.
    Guchelaar, Henk-Jan
    van Erp, Nielka P.
    den Hartigh, Jan
    Burger, David M.
    van Laarhoven, Hanneke W. M.
    THERAPEUTIC DRUG MONITORING, 2015, 37 (04) : 501 - 507
  • [48] The effect of tobacco on lung cancer risk depends on CYP2D6 activity
    Bouchardy, C
    Benhamou, S
    Dayer, P
    CANCER RESEARCH, 1996, 56 (02) : 251 - 253
  • [49] Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients
    Solai, LK
    Pollock, BG
    Mulsant, BH
    Frye, RF
    Miller, MD
    Sweet, RA
    Kirshner, M
    Sorisio, D
    Begley, A
    Reynolds, CF
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (05) : 481 - 486
  • [50] Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population
    Cai, W. M.
    Chen, B.
    Zhang, W. X.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) : 95 - 98
12345